APA (7th ed.) Citation

Crowell, P. D., Giafaglione, J. M., Jones, A. E., Nunley, N. M., Hashimoto, T., Delcourt, A. M., . . . Goldstein, A. S. (2023, October). MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Cell Reports.

Chicago Style (17th ed.) Citation

Crowell, Preston D., et al. "MYC Is a Regulator of Androgen Receptor Inhibition-induced Metabolic Requirements in Prostate Cancer." Cell Reports Oct. 2023.

MLA (9th ed.) Citation

Crowell, Preston D., et al. "MYC Is a Regulator of Androgen Receptor Inhibition-induced Metabolic Requirements in Prostate Cancer." Cell Reports, Oct. 2023.